Topic

Symdeko / Symkevi (tezacaftor/ivacaftor)

A collection of 23 issues

Getting Symdeko Covered by UnitedHealthcare in Texas: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Fast Track to Symdeko Coverage UnitedHealthcare covers Symdeko with prior authorization for eligible CF patients in Texas. The fastest path: 1) Confirm your F508del genotype with FDA-cleared testing, 2) Have your CF specialist submit the UnitedHealthcare PA form with required documentation, 3) If denied, file an internal appeal

Renewing Symdeko/Symkevi Coverage with Blue Cross Blue Shield in Ohio: Complete Timeline and Documentation Guide

Answer Box: Renewing Symdeko/Symkevi Coverage in Ohio To renew Symdeko/Symkevi (tezacaftor/ivacaftor) coverage with Blue Cross Blue Shield Ohio, submit your renewal request 30 days before your current authorization expires. Required documents include updated CF specialist notes, current pulmonary function tests (FEV1), liver function labs, and evidence of

How to Get Symdeko/Symkevi Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization Guide

Answer Box: Getting Symdeko/Symkevi Covered by UnitedHealthcare in New Jersey Symdeko (tezacaftor/ivacaftor) requires prior authorization through UnitedHealthcare/OptumRx in New Jersey. Key requirements: CF specialist prescription, FDA-cleared genotype testing showing F508del mutation, documented diagnosis (ICD-10 E84.x), and age ≥6 years. The medication is Tier 5 (specialty) with

How to Get Symdeko/Symkevi (Tezacaftor/Ivacaftor) Covered by Cigna in New York: Complete Timeline & Appeals Guide

Quick Answer: Getting Symdeko/Symkevi Covered by Cigna in New York Symdeko/Symkevi requires prior authorization from Cigna, typically taking 1-3 weeks with complete documentation. The fastest path: (1) Have your CF specialist submit genetic testing results proving F508del or qualifying mutations, (2) Include a detailed medical necessity letter, and

How to Get Symdeko/Symkevi Covered by Humana in Michigan: Appeals Guide and State Protections

Answer Box: Getting Symdeko/Symkevi Covered by Humana in Michigan Symdeko/Symkevi (tezacaftor/ivacaftor) is typically not on Humana's standard formulary, requiring prior authorization or formulary exception. In Michigan, you have strong appeal rights through both Humana's process and state external review. First step today: Contact

Getting Symdeko/Symkevi Covered by UnitedHealthcare in Florida: Complete Prior Authorization Guide

Answer Box: Fastest Path to Approval Symdeko/Symkevi requires prior authorization from UnitedHealthcare in Florida. To get approved: (1) Have your CF specialist submit a PA request with genotype documentation showing F508del mutation via UnitedHealthcare's Provider Portal, (2) Include a medical necessity letter detailing your CF diagnosis and

How to Get Symdeko/Symkevi Covered by Cigna in Illinois: Prior Authorization Forms, Appeals Timeline & Documentation Guide

Quick Answer: Getting Symdeko/Symkevi Approved by Cigna in Illinois Eligibility: Cigna covers Symdeko (tezacaftor/ivacaftor) for cystic fibrosis patients age 6+ with specific CFTR mutations, prescribed by a pulmonologist or CF specialist. Fastest path: Have your CF specialist submit prior authorization with genetic testing results, clinical notes, and medical

How to Get Symdeko (Tezacaftor/Ivacaftor) Covered by Humana in Texas: Appeals, Forms & State Protections

Answer Box: Getting Symdeko Covered by Humana in Texas Fastest path to approval: Submit prior authorization with genetic testing results, CF diagnosis documentation, and specialist letter through Humana's provider portal or fax to 1-877-486-2621. If denied, you have 65 days to appeal under Medicare rules, or use Texas

Getting Symdeko/Symkevi Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization Guide

Answer Box: Getting Symdeko/Symkevi Covered by UnitedHealthcare in North Carolina Symdeko (tezacaftor/ivacaftor) requires prior authorization from UnitedHealthcare in North Carolina. Your CF specialist must submit documentation including genetic testing results confirming eligible CFTR mutations (like F508del), diagnosis codes, and clinical notes. Initial approval lasts 6 months with reauthorization

Getting Symdeko (Tezacaftor/Ivacaftor) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization Guide

Answer Box: Your Path to Symdeko Coverage in Virginia Symdeko (tezacaftor/ivacaftor) requires prior authorization from UnitedHealthcare, with specific genotype documentation and specialist requirements. The fastest path: 1) Confirm F508del mutation status via FDA-cleared testing, 2) Have your CF specialist submit UnitedHealthcare's Symdeko Prior Authorization form with complete